Who owns GT BIOPHARMA INC COM NEW?
- Ticker: GTBP
- CUSIP Number: 36254l308
Tip: Access positions for across all investors
Analyze quarterly positions in Gt Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gt Biopharma stock
Who bought or sold GT BIOPHARMA INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | 1.2M | $36M | 22% | Sep 2024 |
|
| Geode Capital Management | 15k | $35k | 34% | Sep 2024 |
|
| Vanguard Group | 11k | $30k | -49% | Jun 2024 |
|
| Susquehanna International | 10k | $23k | -47% | Sep 2024 |
|
| Wells Fargo & Company | 10k | $23k | 0% | Sep 2024 |
|
| BlackRock | 9.8k | $28k | -4% | Jun 2024 |
|
| BlackRock | 9.7k | $23k | 100% | Sep 2024 |
|
| Tower Research Capital | 2.2k | $6.2k | -6% | Jun 2024 |
|
| Morgan Stanley | 266.00 | $752.992800 | 0% | Jun 2024 |
|
| Bank of America Corporation | 27.00 | $61.940700 | 0% | Sep 2024 |
|
| Advisor Group Holdings | 12.00 | $27.428400 | -62% | Sep 2024 |
|
| Blue Bell Private Wealth Management | 10.00 | $23.000000 | 0% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 6.00 | $13.999800 | 0% | Sep 2024 |
|
| Royal Bank of Canada | 5.00 | $0 | -29% | Sep 2024 |
|
| Jpmorgan Chase & Co | 1.00 | $2.000000 | 0% | Sep 2024 |
|
Who sold out of Gt Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Front Row Advisors | Jun 2024 | 1.00 | $3.000000 |